Edward Lanphier

Edward Lanphier is an experienced biotech industry executive currently serving as the Executive Chair at Gerostate Alpha, a company focused on aging research and interventions.12

Career Highlights

Lanphier brings over 30 years of experience in the biotechnology industry to his role at Gerostate Alpha.2 His career has been marked by significant achievements:

• Founder and CEO of Sangamo Therapeutics: Lanphier served as President and CEO of Sangamo Therapeutics for 21 years (1995-2016), where he played a pioneering role in the field of genome editing.12

• Leadership Roles: Prior to Sangamo, he held executive positions at several biotech companies, including:

  • EVP Commercial Development at Somatix Therapy Corporation (1992-1997)
  • SVP Business Development & Marketing at Celtrix Pharmaceuticals (1991-1992)
  • President & CEO of BioGrowth Inc. (1988-1991)
  • VP Corporate Development at Biotherapeutics Inc. and Synergen Inc.1

Expertise and Contributions

Lanphier is known for his expertise in:

• Growing biotech companies from inception to publicly traded entities
• Developing therapeutics from bench to bedside
• Pioneering work in genome editing2

His experience also includes a stint in strategic business planning for biotechnology at Eli Lilly and Company from 1982 to 1984.1

Education

Lanphier holds a BA in Biochemistry from Knox College, which he attended from 1974 to 1978.1

Current Role

At Gerostate Alpha, Lanphier contributes to the company's mission of extending healthspan and lifespan through scientific research and interventions in the biology of aging.2 His extensive experience in the biotech industry makes him a valuable asset to the company's leadership team.